RODERICK WONG - 13 Jun 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director, 10%+ Owner
Signature
/s/ Martin Wilson, as attorney-in-fact
Issuer symbol
RCKT
Transactions as of
13 Jun 2024
Transactions value $
$50,008
Form type
4
Filing time
20 Jun 2024, 16:10:30 UTC
Previous filing
26 Jun 2023
Next filing
18 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +23,944 $0 23,944 13 Jun 2024 Common Stock 23,944 $22.86 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $50,008 +3,325 $15.04 3,325 13 Jun 2024 Common Stock 3,325 $22.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 23,944 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025.
F2 This option represents a right to purchase a total of 3,325 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2025. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000.